摘要
背景:小檗碱(BBR)对阿尔茨海默病(AD)等多种脑部疾病具有神经保护作用。淀粉样β(Aβ)老年斑是AD最典型的病理标志. β由β-分泌酶(β-位淀粉样前体蛋白切割酶1,BACE 1)和γ-分泌酶连续切割产生.我们的工作目的是调查神经保护剂 丁腈橡胶对AD的抑制作用与抑制A型β的病理改变有关。 方法:采用Morris水迷宫(MWM)实验评价小鼠的认知功能。酶联免疫吸附法检测Aβ水平;APP、SAPPα、ADAM 10和AD的表达 Westernblotting检测AM 17、SAPPβ和BACE 1,免疫组化法检测γ-分泌酶复合物(NCT、PS1、APH-1α和Pen-2)的活性。 结果:BBR可改善APP/PS1小鼠的学习记忆障碍。BBR可降低APP/PS1小鼠海马Aβ水平。bbr治疗组bce 1和sapp-β水平显著升高。 在AD小鼠海马中诱导。BBR能显著降低PS1、APH-1、α和Pen-2的表达,但对NCT无明显影响。bbr治疗后海马Sappα、ADAM 10和ADAM 17水平的变化 小鼠与对照组比较,差异有显着性(P<0.05)。 结论:丁咯烷酮能抑制AD小鼠海马β/γ-分泌酶活性,增强α-分泌酶,降低海马Aβ水平,改善阿尔茨海默氏样认知障碍。
关键词: 小檗碱,认知功能障碍,淀粉样β,β-分泌酶,γ-分泌酶,神经变性。
Current Alzheimer Research
Title:Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases
Volume: 15 Issue: 11
关键词: 小檗碱,认知功能障碍,淀粉样β,β-分泌酶,γ-分泌酶,神经变性。
摘要: Background: Berberine (BBR) has neuroprotective effects on many brain diseases, including Alzheimer’s disease (AD). Amyloid -beta (Aβ) senile plaque is the most classical pathological hallmarks of AD. Aβ produces from a sequential cleavage by β-secretase (beta-site amyloid precursor protein cleaving enzyme 1, BACE1) and γ -secretase. The aim of our work was to investigate whether the neuroprotective effects of BBR on AD is related to inhibiting Aβ pathology.
Method: The cognitive function of mice was assessed by the Morris water maze (MWM) test. The Aβ levels were determined by enzyme linked immunosorbent assay; the expression of APP, sAPPα, ADAM10 and ADAM17, sAPPβ and BACE1 was detected by Western blotting; and the activity of γ -secretase complex (NCT, PS1, Aph-1α and Pen-2) was determined by Western blotting and immunohistochemistry.
Results: BBR improved learning and memory deficits of APP/PS1 mice. BBR decreased Aβ levels in the hippocampus of APP/PS1 mice. BACE1 and sAPP -β levels in the BBR-treated groups were significantly reduced in the hippocampus of AD mice. BBR markedly decreased the expression of PS1, Aph-1α and Pen-2, but had no effect on NCT. The levels of sAPPα, ADAM10 and ADAM17 in the hippocampus of BBR-treated mice significantly increased, compared with the control ones (P<0.05).
Conclusion: BBR inhibits the activity of β/γ-secretases, enhances α-secretases, and lowers the Aβ level in the hippocampus of AD mice, and improves Alzheimer’s-like cognitive impairment.
Export Options
About this article
Cite this article as:
Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases, Current Alzheimer Research 2018; 15 (11) . https://dx.doi.org/10.2174/1567205015666180702105740
DOI https://dx.doi.org/10.2174/1567205015666180702105740 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Calcium Channel Mutations in Cardiac Arrhythmia Syndromes
Current Molecular Pharmacology Future of Spermatogonial Stem Cell Culture: Application of Nanofiber Scaffolds
Current Stem Cell Research & Therapy Human Mesenchymal Stem Cells (hMSCs) as Targets of DNA Damaging Agents in Cancer Therapy
Current Cancer Drug Targets Non-Alcoholic Fatty Liver Disease in Children
Current Nutrition & Food Science Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety
Current Gene Therapy Phase II Drug Metabolism and Individualized Drug Therapy: A Focus on Functional Genetic Variation in UDP-Glucuronosyltransferases
Current Pharmacogenomics and Personalized Medicine Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy
CNS & Neurological Disorders - Drug Targets Anti-Hyperglycemic and Hypolipidemic Effects of Different Aloe vera (Aloe Barbadensis Miller) Extracts in the Management of Obesity and Diabetes
Current Nutrition & Food Science Natural Compounds Therapeutic Features in Brain Disorders by Experimental, Bioinformatics and Cheminformatics Methods
Current Medicinal Chemistry Blockade of Neoangiogenesis, a New and Promising Technique to Control the Growth of Malignant Tumors and their Metastases
Current Vascular Pharmacology Albert Ellis Rational-Emotive Behavior Therapy
Adolescent Psychiatry KSP Inhibitors as Antimitotic Agents
Current Topics in Medicinal Chemistry AMPK As A Target in Rare Diseases
Current Drug Targets Development and Application of Fourier-Transform Infrared Chemical Imaging of Tumour in Human Tissue
Current Medicinal Chemistry Fecal Microbiota Transplant: Latest Addition to Arsenal against Recurrent <i>Clostridium difficile</i> Infection
Recent Advances in Anti-Infective Drug Discovery Sam Domains in Multiple Diseases
Current Medicinal Chemistry HSP70 Family in the Renal Inflammatory Response
Inflammation & Allergy - Drug Targets (Discontinued) Structure-Function Relationships and Clinical Applications of L-Asparaginases
Current Medicinal Chemistry Magnetic Nanoparticles in Brain Disease Diagnosis and Targeting Drug Delivery
Current Nanoscience A Synopsis of Nano-Technological Approaches Toward Anti-Epilepsy Therapy: Present and Future Research Implications
Current Drug Metabolism